GALMED PHARMACEUTICALS LTD. Earnings Per Share (Basic)
GALMED PHARMACEUTICALS LTD. (GLMD) reported Earnings Per Share (Basic) of $2.86 per share for the 3-month period ending 2026-06-30, per its 6-K filed 2026-09-02.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-09-02
- GALMED PHARMACEUTICALS LTD. earnings per share, basic for the quarter ending 2026-06-30 was $2.86, a 43.48% decline year-over-year.
- GALMED PHARMACEUTICALS LTD. earnings per share, basic for the quarter ending 2025-12-31 was -$0.80.
- GALMED PHARMACEUTICALS LTD. earnings per share, basic for the quarter ending 2025-09-30 was $0.33, a 85.71% decline year-over-year.
- GALMED PHARMACEUTICALS LTD. earnings per share, basic for the quarter ending 2025-06-30 was $5.06, a 206.67% increase year-over-year.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.86 6-K · filed 2026-09-02 | $5.21 6-K · filed 2026-09-02 | |||||
| 2025-12-31 | -$0.80 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$1.17 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$2.31 derived: net income ÷ weighted average shares · filed 2026-09-02 | $2.39 20-F · filed 2026-03-31 | |||
| 2025-09-30 | $0.33 6-K · filed 2025-11-26 | -$1.47 derived: net income ÷ weighted average shares · filed 2026-09-02 | $1.47 6-K · filed 2025-11-26 | ||||
| 2025-06-30 | $5.06 6-K · filed 2026-09-02 | $0.63 6-K · filed 2025-08-28 | $10.04 6-K · filed 2026-09-02 | $1.25 6-K · filed 2025-08-28 | |||
| 2024-12-31 | -$2.00 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$4.21 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$6.01 derived: net income ÷ weighted average shares · filed 2026-03-31 | $8.08 20-F · filed 2026-03-31 | |||
| 2024-09-30 | $2.31 6-K · filed 2025-11-26 | -$4.02 derived: net income ÷ weighted average shares · filed 2025-11-26 | $6.11 6-K · filed 2025-11-26 | ||||
| 2024-06-30 | $1.65 6-K · filed 2025-08-28 | $0.18 6-K · filed 2024-08-28 | $3.72 6-K · filed 2025-08-28 | $0.41 6-K · filed 2024-08-28 | |||
| 2023-12-31 | $30.00 20-F · filed 2026-03-31 | $2.50 20-F · filed 2024-04-04 | |||||
| 2023-06-30 | $0.95 6-K · filed 2024-08-28 | $2.04 6-K · filed 2024-08-28 | |||||
| 2022-12-31 | $127.80 20-F · filed 2025-04-02 | $0.71 20-F · filed 2023-03-29 | |||||
| 2022-06-30 | $2.25 6-K · filed 2023-08-09 | $0.15 6-K · filed 2022-08-04 | $5.85 6-K · filed 2023-08-09 | $0.39 6-K · filed 2022-08-04 | |||
| 2021-12-31 | $19.80 20-F · filed 2024-04-04 | $1.32 20-F · filed 2022-05-02 | |||||
| 2021-06-30 | $0.33 6-K · filed 2022-08-04 | $0.72 6-K · filed 2022-08-04 | |||||
| 2020-12-31 | $1.35 20-F · filed 2023-03-29 | ||||||
| 2019-12-31 | $0.97 20-F · filed 2022-05-02 |